The study aims to explore the association between the MMP-3 genotype and the risk of developing pterygium.
Genetic analysis focusing on MMP-3 rs3025058 variant
Assessment of its role in susceptibility to pterygium
Evaluation of extracellular matrix (ECM) regulation.
Identified MMP-3 rs3025058 as a potential genetic biomarker for pterygium risk
Found evidence of ECM dysregulation linked to this genotype
Suggested implications for disease progression and risk assessment.
Abstract
MMP-3 rs3025058 may serve as a genetic biomarker for pterygium susceptibility prediction, potentially contributing to ECM dysregulation and disease progression.